IMS site is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
22 - 24 September 2021
JusticeDelhi High Court
Deputy Chief Administrative Patent Judge, Patent Trial and Appeal Board (PTAB) U.S. Patent and Trademark Office
Attorney McAndrewsHeld & Malloy, Ltd.
Partner and Intellectual Property Department ChairLocke Lord LLP
Vice President- Global IP HeadIntas Pharmaceuticals Ltd.
General Manager - Global IPZydus Cadila
Chief IP Counsel - Global Head IPRBiocon
General Manager - Global IPZydus Cadilla
Sr.Vice President Legal and Group GCWockhardt
PartnerRakoczy Molino Mazzochi Siwik LLP
Assistant Commissioner for PatentsUSPTO
Chairperson, Fifth Board of AppealEuropean Union Intellectual Property Office
General Manager & Head - Global IP, Product Portfolio and Corporate StrategyPanacea Biotec
Associate Vice President - IPDr. Reddy's Laboratories
Vice President - IPMGlenmark Pharmaceuticals
Sr. GM - IPR LegalMylan Laboratory
PartnerLocke Lord LLP
Sr. GM - IP SpecialityAurobindo
Head IPRNeuland Labs
Sr. Director & Head-Business DevelopmentPortfolio & Strategy at Kashiv BioSciences LLC
Director (Head) - Intellectual Property ManagementFresenius Kabi Oncology Ltd
General CounselMankind Pharma Limited
Head IP - Product PortfolioHikal Ltd
PartnerUpadhye Tang LLP
General Manager- IPMGlenmark Pharmaceuticals Ltd
Sr. General Manager & Head – Corporate IPPiramal Pharma Global
Senior IP ConsultantIndoco Remedies Ltd
Vice Prresident and Head Portfolio Planning and IP LitigtaionSun Pharma
AssociateLocke Lord LLP
Delhi High Court
Justice Prathiba M. Singh completed her 5- year law course from University Law College,
Bangalore. She graduated as the 1st Rank holder from Bangalore University and also represented
India at the Philip C Jessup Moot Court competition in Chicago, USA. She was offered the
ODASSS scholarship by the Cambridge Commonwealth Trust to study LL.M at the University of
Cambridge (U.K.). She enrolled with the Bar in 1991.
Before being elevated to the Bench, she was a leading Intellectual Property lawyer in India. She
had the distinction of handling landmark matters in all areas of IPR laws including patents,
trademarks, designs, copyright, plant varieties, internet laws, etc. As Managing Partner of Singh
& Singh, she advised clients and handled cases relating to commercial disputes, arbitration,
telecom, broadcasting laws, media laws, writs, regulatory issues, education etc. She has
regularly appeared before the Hon'ble Supreme Court of India, High Court of Delhi, TDSAT,
IPAB, Trademark and Patent Offices. She was appointed as Amicus Curiae by the High Court of
Delhi to streamline the working of the Copyright Office. She was also appointed on a High Level
Committee for streamlining of Patent examinations.
She was invited as an expert to present views to the Parliamentary Committees considering
amendments to the Patents Act in 2002, Copyright Amendment Act, 2012, Geographical
Indications Act etc.
Mrs Singh was designated as a Senior Advocate by the Delhi High Court in December 2013.
The Prathiba M. Singh Scholarship for LL.M. students was instituted at the University of
Cambridge in 2013. Scholarships are granted to Indian students who have secured admission at
Cambridge, for pursuing their LLM course. Recently, she has been invited by the Vice
Chancellor, Cambridge University to be part of the “Circle of Advisors” for India.
She was a member of the IPR Think Tank, which was entrusted with the momentous task of
drafting India’s first `National IPR Policy’ which was released in May, 2015. She has also been
awarded as “30 Most Powerful Business Women in India” Award by the Business Today Group
in September 2018.
Her articles `India – Look behind the headlines’, `India is a game-changer in Patent laws’,
`Implementation of the Commercial Courts Act’, `CRI guidelines’, ‘Expedited trials in patent cases’ etc.,
have been published in leading international and national publications.
During her tenure as the President of APAA (Indian Group), several important initiatives were
taken including filing of a writ petition seeking constitution of the IPAB as also the creation of the
Delhi court-room complex for the IPAB. She has been a regular Speaker at various National and
International IP related workshops, seminars and events. She was also a member of the CII
National Steering Committee on IPRs.
Various awards given to her include, ‘IP Litigator of the Year, 2012’, the ‘Asia women in Business
Law Awards’ given by Managing IP for excellence in Litigation, ‘IP Lawyer of the Year, 2013’ by
Legal Era, ‘Best IP Senior Counsel of the Year - 2014’ by Legal Era and ‘Woman Lawyer of the year,
2015’ by the Indian National Bar Association.
She was a Member of various professional bodies including SCBA, DHCBA, INTA, APAA,
AIPPI, IPAA, IPLPA, and Telecom Lawyers Association.
She was elevated as a Permanent Judge of the High Court of Delhi on 15th May 2017.
Deputy Chief Administrative Patent Judge, Patent Trial and Appeal Board (PTAB)
U.S. Patent and Trademark Office
The Honorable Jacqueline Wright Bonilla serves as Deputy Chief Administrative Patent Judge at the Patent Trial and Appeal Board (PTAB) at the U.S. Patent and Trademark Office. Since her appointment as an Administrative Patent Judge in January 2012, she has conducted numerous post-grant patent trials under the America Invents Act, heard appeals from adverse examiner decisions in patent applications and reexamination proceedings, and rendered decisions in interferences. In her current role, she helps lead the PTAB as it handles cases and renders decisions in all areas of its jurisdiction. Previously, she worked for twelve years in private practice, including as a partner at Foley & Lardner, LLP. She also served as a judicial law clerk to the now-retired Chief Judge Randall Rader at the U.S. Court of Appeals for the Federal Circuit. Judge Bonilla graduated from the University of Virginia School of Law, and holds a Ph.D. in Pharmacology from the University of Virginia, and a B.A. in Biochemistry from the University of California, Berkeley.
Held & Malloy, Ltd.
Partner and Intellectual Property Department Chair
Locke Lord LLP
Vice President- Global IP Head
Intas Pharmaceuticals Ltd.
Dr. Alpesh Pathak is currently Vice President - Global IP Head at Intas Pharmaceuticals Ltd.
Dr. Alpesh has also written two books Entitled “Protecting Patent Fundamentals” and “Understanding Global patent litigations through landmark judgements – A litigation ready reckoner” which is well appreciated in patent professionals and major universities wherein patent is one of the value-added subject in the respective technical discipline. The second book is just published.
Dr. Alpesh Pathak has received an international award for the Top 50 In-house counsel in Singapore and also received several other awards for his contribution in the field of Intellectual Property since last more than two decades.
Having spent more than two decade in the field of IP, he works on a variety of intellectual property matters at Intas at Global Level, including IP due diligence of Biosimilar, IP activities for 351(k) filing, FTF Para IV filing, handling patent litigations across the globe and related activities, drafting and prosecution of patent applications, drafting and negotiation of intellectual property agreements with third parties, and due diligence analyses in supporting in-licensing and out-licensing activities.
Prior to joining Intas, Dr. Alpesh has worked with some of the leading pharmaceutical companies like Alembic Ltd, Lupin Ltd., Zydus Cadila and Cadila Pharmaceuticals. Alpesh holds a PhD degree from The Sardar Patel University. Dr. Alpesh Pathak is a registered Patent agent. Besides having PG diploma in Patent Law degree from Nalsar Uni, Hyderabad, he has undergone various specialized courses on US litigations and European patent practices. He has completed Masters from the Sardar Patel University, and a B.Sc. from the Same University with specialization in organic chemistry. Dr. Alpesh is also active in certain knowledge development programs for creating IP awareness by conducting lectures in various universities and conferences in India and abroad. He also currently a visiting faculty at Sardar Patel University and Gujarat Technical University (GTU).
Dr. Alpesh Pathak has contributed as speaker in more than 90 leading IP conferences/Seminars/workshop across the globe.
General Manager - Global IP
Chief IP Counsel - Global Head IPR
Arshad Jamil is a senior Indian Patent Attorney with extensive experience in the legal and IP rights fields. Arshad is the Chief IP counsel and Global head of IP rights at Biocon Biologics, where he is responsible for the Biocon Group’s patent and trademark filings and policy, and handling Global litigation for Biosimilarsand ANDAs . Arshad manages Biocon group of companies IP portfolio of 1100+ global patents and 950+ global trademarks.
In his previous assignment,Arshad was a Senior Patent Attorney at Sun Pharma, where he handled ANDA litigations, including Hatch Waxman settlements. He received his Bachelor of engineering (B.E.) from Mysore University in 1991 and his Bachelor of Laws(LL.B.) from Meerut (CCS) University in 1998. In 2014 he completed the SP Jain Institute of Management and Research postgraduate executive management programme.Arshad is a distinguished speaker at National /International IP forums and recognised by IAM as The World’s leading IP strategists consecutively for 4 years 2017 ,2018, 2019, and 2020 editions of IAM strategy 300.
Having more than 15 years of experience in the field of IntellectualProperty Rights (IPR) - especially Patents - associated withPharmaceutical formulation aspects.
Working on various IP aspects like:
Sr.Vice President Legal and Group GC
Ms. Debolina Partap, Sr.Vice President Legal and Group GC, Wockhardt, is a Gold Medalist in masters of law and has 28 years of experience in banking, finance, pharma and healthcare. She is responsible for all corporate legal work, M&As, IP and Litigation Management, legal compliance, transactions management amongst others. She advises top management on legal risks to the organization. She has contributed tremendously to Covid 19 vaccine contracts. Her main achievements come in settling complex financial cases and arbitrations filed against Wockhardt Limited, complex multi-jurisdictional arbitrations on commercial disputes and settling intricate derivatives suits filed against Wockhardt group globally. She is also handling legal issues pertaining to complex and composite global regulatory matters concerning Wockhardt Group. She is one of the few general counsels globally who handle forensics and data analytics. She and her team have won over 100 awards from internationally and nationally recognized legal organizations.
Rakoczy Molino Mazzochi Siwik LLP
Assistant Commissioner for Patents
Chairperson, Fifth Board of Appeal
European Union Intellectual Property Office
Gordon Humphreys is currently Chairperson of the First Board and of the Third Board of Appeal
at EUIPO, from 2014 to 2019 he had been Chairperson of the Fifth Board of Appeal, having
joined the Boards as a Member in 2005. He was Head of the Register Service from 2002-2005
and joined EUIPO’s Legal Department in 1997. He is also an accredited mediator with the
Chartered Institute of Arbitrators and is a member of the EUIPO Boards of Appeal Mediation
Service since 2011.
Prior to working at EUIPO, Gordon was in private practice in Luxembourg and Brussels and
qualified both as a barrister (England and Wales) and avocat (Brussels bar). He was also a
member of the CIArb Sub-Committee on Revision of Mediation Rules between 2016 and 2018.
Gordon was educated at the universities of Buckingham (LL.B), Cardiff (LL.M), Liège (masters
in economic law) and Alicante (specialist en derecho de la Unión Europea).
Gordon speaks and writes regularly on ADR, trade mark and design matters, and has recently
co-edited Mediation: Creating Value in International Intellectual Property Disputes, Wolters
Kluwer (2018) and was a contributing author in Hasselblatt, Community Design Regulation:
Article-by-Article Commentary, Second Edition (2018), Beck.
General Manager & Head - Global IP, Product Portfolio and Corporate Strategy
Associate Vice President - IP
Dr. Reddy's Laboratories
Dr. M Jayakumar(Jay) is Associate Vice Presidentof Intellectual Property at Dr Reddy's Laboratories Ltd., an Indian multinational pharmaceutical companyaimed to bring access to affordable and innovative medicines, becauseDr. Reddy’s believe, “Good Health Can’t Wait.”
At Dr. Reddy’s, Jay is responsible for devising IP strategies and supports various programs from product ideation to commercial launch. He specializes in patent analysis, identifying & mitigating IP risks, portfolio analysis, technology mapping/ scouting, patent drafting & prosecution,and portfolio management.He further supports in various transactional activities, in particular monetization, licensing, merger and acquisition.
Jay helps in building IP assets in a structured approach, keeping in mind of complex regulatory requirements and longer product developmental cycle. He developed robust strategies to create IP assets, that added value in transactional activities.
Before Dr. Reddy’s, Jay was working with a global pharmaceutical company, in mitigating IP risks and litigation.
Jay has over 19 years of experience in pharmaceutical industry, in IP and Research& Development. He holds a M. Pharm and PhD degree in pharmaceutical technology, a law degree (LLB), and also completed Executive Program in Business Management from IIM Calcutta. He is a frequent speaker at various conferences, and a mentor for innovation building and IP creation. He hasfeatured in the IAM Strategy 300 as one of the world’s leading IP strategist.
Vice President - IPM
Sr. GM - IPR Legal
Myoka “Miki” Goodin is a Partner based in the Chicago office of Locke Lord LLP and is a member of the Firm’s Executive Committee. Miki holds a Bachelor’s degree in Molecular and Cellular Biology from the University of California at Berkeley and obtained her law degree from the University of Southern California Gould School of Law. Miki focuses her practice on complex intellectual property litigation matters with a primary emphasis on disputes involving the Hatch-Waxman provisions of the Patent Act and the Federal Food, Drug and Cosmetic Act. MikiGoodin has advised clients on regulatory issues before the U.S. Food and Drug Administration, has counseled and represented clients on various antitrust-related matters, including those relating to patent enforcement and settlement, and helps clients develop
strategies for filing abbreviated or 505(b)(2) new drug applications.
Sr. GM - IP Speciality
Dr. Nehal Bhatt has about 18 years of experience of working in the field of Intellectual Property in Pharmaceutical Industry. He is presently working as Senior General Manager, Intellectual property with focus on Speciality Products in Aurobindo Pharma Ltd, Hyderabad. He was associated with companies such as Amneal Pharmaceuticals, Actavis(was Allergan and now Teva), Glenmark Pharmaceuticals and Cadila Pharmaceuticals in past. He has been working in the areas of strategizing non-infringement or invalidity positions and litigation management for different geographies including US, EP and CA, patent filing and prosecution, IP due diligence for mergers and acquisitions, compliance of statutory obligations connected with PIV filings or 505b2 filings in US and MA filings in EU, product identification/selection support to strengthen company’s pipeline.
Dr. Nehal Bhatt is a pharmacy post-graduate from L.M.College of Pharmacy, PhD in Phamaceutical sciences and Post Graduate Diploma in Patent Law. He is a Registered Patent Agent. He has additionally a Diploma in Business Administration from ICFAI
Dr.P.S.R.C.Murthy is presently heading IPR department of Neuland Laboratories Limited, Hyderabad, earlier headed IPR department of Suven Life Sciences Ltd and worked as a Scientist in IPR department of Dr.Reddy’s Laboratories Ltd.
I am having rich, hands-on experience in all aspects of IP. Experience in handling IP for API’s, formulations, NCE’s and Peptides. With experience spanning over 19+ years, myself worked on all major IP concepts like IP creation, IP protection, IP commercialization, IP portfolio management, IP strategy, IP Litigation, IP licensing, Innovation management, Prosecution strategy for patents, creation of patent families for technology picket fencing, Ideation for 505(b)(2) opportunities, Patent drafting, Patent filing, Patent prosecutation, Negotiation and preparation of various IP related agreements, IP training and IPR team building.
Dr.P.S.R.C.Murthy is known as hardcore scientist and inventor, there are over 15 publications including patents, papers and posters.
Intiated and Implemented best IP practices in Dr.Reddy’s, Suven & Neuland Laboratories Ltd resulted lot of awards and saved crores of IP expenditure.
Sr. Director & Head-Business Development
Portfolio & Strategy at Kashiv BioSciences LLC
Dr. Paras Vasanani is presently associated with Kashiv BioSciences LLC (US based innovator pharma company) as Sr. Director & Head Business development, Portfolio & Strategy.
Kashiv is a USA based pharma and biotech company working on Biosimilars, 505b2, NCEs & complex generics. Dr. Paras has started his career as IP professional from Alembic Pharma then Zydus Pharma then Amneal Pharma and currently working at Kashiv BioSciences with vast experience in the area of Intellectual Property Management, portfolio selection and business development activities. He has attended many litigations at US district court & CAFC in person. In the field of IP he has worked for various countries like USA, India, Europe, Canada, Mexico, Brazil and Australia.
Dr. Paras has pursued M.Pharm and Ph.D. with specialization in the field of Pharmaceutical Sciences from M.S.University, Vadodara. He did his MBA from IIM-Ahmedabad. He is registered Indian Patent Agent and Trademark Agent. He has more than 10 patents on his name as inventor. He remained as spoke person at various National & International Conferences, Symposiums and Universities.
Director (Head) - Intellectual Property Management
Fresenius Kabi Oncology Ltd
I am doctorate in Organic Chemistry, MBA and Law graduate. I am a Registered Indian Patent Agent with about 20 Years of experience in Leading Pharmaceutical Companies like Alembic, Ranbaxy (Presently Sun), Teva Pharmaceuticals and Fresenius Kabi Oncology Ltd.
I have more than 18 Years of experience as a Patent Professional and handled a wide sphere of Technological Areas of Patents – Chemistry, Polymorph, Formulations, Drug Delivery Systems, Indication, Biotechnology & Biosimilars, Medical devices and Nutrition.
Currently I am responsible for all the Patent matters globally by supporting and Advising to the Research & Development, Business and Allied Functions of the Organization by ensuring hassle free product launch. Also exploring early market entry opportunities by designing around and challenging Road block Patents/applications. I handled drafting and prosecution of more than 200 Patent Applications. I am successfully involved in Indian opposition and Litigation of Patent matters. Also I work on identification of new and potential products, for the inclusion in product portfolio grid
Mankind Pharma Limited
Prateush has a rich corporate experience of 17-years stint with Indian Customs, four years with Viraj Profiles and a further four years with the law firms MV Kini and Co and Kochar and Co. At Indian Customs, where he began his career in 1991, Prateush was instrumental in setting up the first private port and CFs.
At Viraj Profiles Limited, the world’s leading manufacturer of stainless steel long products, Prateush’s portfolio included legal and regulatory matters, taxation, strategy planning, liaising and coordination, statutory compliances, labour matters, contracts, agreements and acquisitions. He was responsible for health checks and internal and statutory audits. He acted as a bridge and point of contact between all supporting functions and businesses for resolving issues and risk mitigation. He liaised with government agencies and ministries at the state and Centre. His tenure with MV Kini and Co and Kochar and Co saw him handling regulatory representation and litigation, providing advice on antidumping matters, statutory compliances and the setting up and de-bonding of SEZ, STPI and EOU.
In his present position as General Counsel, Chief Risk and Compliance Officer at Mankind Pharma Limited, Prateush has been instrumental in the successful closure of all critical litigation. He has also been effective in handling litigation pertaining to a wide range of statutes relating to the pharmaceutical industry as well as Tax, Employment, Corporate and Anti-Trust laws.
Head IP - Product Portfolio
Upadhye Tang LLP
General Manager- IPM
Glenmark Pharmaceuticals Ltd
Shradha Saraf is currently with Glenmark Pharmaceuticals limited. Prior to Glenmark, she was associated with LupinPharma and Sun Pharma.Shradha’s background combines a post graduate degree in pharmaceutics from NIPER (National Institute of Pharmaceutical Education & Research), Mohali with more than 17 years of industry experience.
Among other things Shradha’s key area of focus includes FTO assessment& design IP strategies across various Regulated and Semi regulated markets with primary focus on North American market. She has IPR experience in both innovative and generic segments which includes small molecules, biologicals, drug device, respiratory, oncologyand all kind of generic, complex generic or super generics. Her expertise also includes managing Hatch Waxman litigations in collaboration with the Counsel.
Sr. General Manager & Head – Corporate IP
Piramal Pharma Global
Experience: 26+ years (16+ years in Corporate IP and prior 10 years as research scientist in Medicinal Chemistry)
Senior IP Consultant
Indoco Remedies Ltd
Swati is an accomplished IP expert. In her career spanning over 26 years, she has been involved in strategic patent portfolio management; drafting and prosecuting over 500 world-wide patent applications; providing legal opinions on patentability, patent infringement, FTO analysis and validity issues, and devising strategies for patent litigation.
Currently, in her role as Senior IP Consultant at Indoco Remedies Ltd., Swati provides strategic expertise on a broad range of IP issues, advises senior management on IP issues that have legal implications, prepares opinions and deals with IP litigations. Prior to joining Indoco, Swati served as In-House Patent Counsel and Head of Patents Dept. at Piramal Healthcare Ltd. overlooking protection of inventions in Drug Discovery Research, process chemistry and formulations. During her tenure, Piramal won Pharmexcil “Platinum Patent Award” in 2014, for securing the most number of patents under overall category. She has also worked as patent professional for leading Indian Pharmaceuticals including Sun Pharma. and Lupin.
Swati is a frequent speaker on emerging areas of patent law at various events. Recognised among “Powerful Women in IP - India 2021” by World Intellectual Property Forum. In the year 2019, Swati received recognition as “IP Star Woman of the Year” from Legal Era Magazine. Also, received recognition amongst “Top 100 Powerful Women in Law” by World Intellectual Property Forum in the year 2017.
Vice Prresident and Head Portfolio Planning and IP Litigtaion
Dr. Taranpreet Singh Lamba is presently working as Vice President of Intellectual Property and Product Portfolio Management in Glenmark Pharmaceuticals Limited, Mumbai. He has more than 19years of rich experience in the patent matters with specific focus in managing patent portfolios, infringement analysis and litigations for various geographies like US, EP, India and Emerging Markets. He is also a Head of Product Portfolio in Glenmark for making future pipeline for key regulated markets including US, Europe.
Dr. Taranpreet Singh Lamba is a pharmacy graduate and has done M. Tech in Pharmaceutical Technology from NIPER and has further also done specialization in patent law.